The US market for obesity interventions will grow moderately through 2027, driven by an increasing obese population and penetration of bariatric procedures due to positive clinical trials and improvements in insurance coverage.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the obesity intervention market in the US across a 10-year period.


Sleeve gastrectomy procedure volumes will grow at the expense of gastric bypass procedures during the forecast period.

What is causing the increase in sleeve gastrectomy procedures?

How will this impact the internal closure device market values?

A number of novel products have recently been FDA approved or are expected to be approved in the near future.

Which products have received FDA approval?

What are the major novel emerging products and how will their entry impact the overall market and the use of existing treatments?

There have been multiple serious safety concerns from the FDA regarding existing bariatric procedures and products.

Which products have been associated with safety concerns?

What efforts have the affected medtech companies made to address these concerns?

How have these concerns and alerts impacted device use and competitor market shares?

Table of contents

  • United States
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • Obesity Intervention Market
      • Market Highlights
      • Market Definitions
      • Epidemiology Forecast Data
      • Procedure Forecast Data
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Reimbursement
        • Clinical Data
        • Product Recalls and Safety Issues
        • Physician Training and Marketing
        • Patient Marketing and Awareness
        • First-Mover Advantage
        • Product Portfolio Management
        • Competition from Alternatives
        • Mergers, Acquisitions, and Partnerships
        • Emerging Technologies
      • Market Developments
    • Gastric Band Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Internal Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Intragastric Balloon Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Emerging Device Market
      • Market Highlights
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): P Prasad, MS

Prasad Pallemsetty is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics. Follow Prasad on Twitter: @PPrasad_DRG


Related Reports

Obesity Interventions | Medtech 360 | Market Insights | Latin America (Supplemental)

The Latin American obesity intervention market will grow through 2026, driven by an increasing obese population and growth of bariatric surgery utilization as a result of positive clinical resul...

View Details

Obesity Interventions | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for obesity interventions will grow through 2024, driven by increasing bariatric surgery procedure volumes—which will positively impact the un...

View Details

Obesity Interventions | Medtech 360 | Market Insights | Latin America

The Latin American obesity intervention market will grow through 2026, driven by an increasing obese population and growth of bariatric...

View Details

Obesity Interventions | Medtech 360 | Market Insights | Middle East (Supplemental)

The Middle East obesity intervention market will grow through 2026, driven by increasing penetration of bariatric procedures and a growin...

View Details